• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Most sexually active students have not been tested for HIV

Article

To assess the relationship between HIV testing and HIV-related risk behaviors in US high school students, investigators examined self-reported data from the 2009 national Youth Risk Behavior Survey for 7,591 students in grades 9 through 12 who reported ever having sexual intercourse.

To assess the relationship between HIV testing and HIV-related risk behaviors in US high school students, investigators examined self-reported data from the 2009 national Youth Risk Behavior Survey for 7,591 students in grades 9 through 12 who reported ever having sexual intercourse.

Of these students, less than a quarter (22.6%) had been tested for HIV. Most likely to be tested were students who had engaged in certain HIV-related risk behaviors: ever having injected any illegal drug, ever being forced to have sexual intercourse, not using a condom at last sexual intercourse, or having had sexual intercourse with 4 or more persons overall. However, no association was found between HIV testing and having sexual intercourse before age 13 years or drug or alcohol use before the last sexual intercourse. White students (54.9% of the sample) were significantly more likely than those of another race/ethnicity to have undergone HIV testing. The odds of having HIV testing also were increased in girls, non-Hispanic blacks, and those in the 11th and 12th grades (Balaji AB, et al. Arch Pediatr Adolesc Med. 2012;166[4]:331-336).

COMMENTARY

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.